CONFIDENCE COMES FROM A PROVEN TRACK RECORD
Medtronic cryoablation is a proven technology that has been used to treat one million people with atrial fibrillation and other cardiac arrhythmias. The safety, efficacy and efficiency of Medtronic cryoablation therapy is supported by over 1200 peer reviewed articles.1
The Arctic Front Advanced™ Cardiac Cryoablation System is leading the way, being already CE marked for AF Ablation in EMEA, and being the first FDA approved Catheter System for persistent AF ablation and first-ablation of paroxysmal AF in the US.
Hear From Prof. Schilling (02:47)
See Prof. Schilling’s perception of the Medtronic cryoablation safety profile
Hear From Prof. De Asmundis (02:47)
Learn more about Medtronic cryoablation safety benefits
References
1
Status: June 2020, Medtronic Data on File [Instruction for use 2017 Medtronic, M970045A001 1A, 2017-10-05. Arctic Front™ Cardiac Cryoablation Catheter System, already CE marked for AF ablation in EMEA, is now the first FDA approved catheter system for paroxysmal and persistent AF ablation in the US].
BRIEF STATEMENT
The Arctic Front Cardiac Cryoablation Catheter System is indicated for the treatment of patients with atrial fibrillation in Europe, the Middle East, and Africa. The Freezor Cardiac CryoAblation Catheter is indicated for the treatment of cardiac arrhythmias.
See the device manual for detailed information regarding the instructions for use, the implant procedure, indications, contraindications, warnings, precautions, and potential adverse events. If using an MRI SureScan™ device, see the MRI SureScan™ technical manual before performing an MRI. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu.
For applicable products, consult instructions for use on www.medtronic.com/manuals. Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.